<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=": Review: Review Hypothetical targets and plausible drugs of coronavirus" exact="infection" post="caused by SARSâ€�CoVâ€�2 ALMASI and MOHAMMADIPANAH AlmasiFaezeh1MohammadipanahFatemehhttps://orcid.org/0000-0003-0286-53421fmohammadipanah@ut.ac.ir[1], Pharmaceutical Biotechnology"/>
 <result pre=", This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
 <result pre="situation due to the recent pandemic of the novel coronavirus" exact="disease" post="(SARSâ€�CoVâ€�2) with the mortality rate passed over 470,000. Attaining"/>
 <result pre="drug discovery are suggested. Emphasizing the potential route of SARSâ€�CoVâ€�2" exact="infection" post="and virus entryâ€�related factors like integrins, cathepsin and ACE2"/>
 <result pre="word-count: AlmasiF, MohammadipanahF. Hypothetical targets and plausible drugs of coronavirus" exact="infection" post="caused by SARS-CoV-2. Transbound Emerg Dis. 2020;00:1â€&quot;15. 10.1111/tbed.13734 1"/>
 <result pre="immune system (Chan etÂ al.,Â 2020). Structurally, the ~30,000 nucleotide" exact="viral" post="genomes also express four basic structural proteins of nucleocapsid"/>
 <result pre="and spike (S), encoding from the 3â€² end of the" exact="viral" post="genome (FigureÂ 1). The spike is a ~150Â kDa"/>
 <result pre="receptor on the host cell and angiotensinâ€�converting enzyme is the" exact="primary" post="stage in its life cycle which is followed by"/>
 <result pre="to the genome of the virus and is necessary for" exact="viral" post="RNA transcription and replication. The other critical structural protein"/>
 <result pre="protein is M protein that is involved in shaping the" exact="viral" post="envelope. By binding to the other proteins, this protein"/>
 <result pre="helps to stabilize N proteins and promotes the ending of" exact="viral" post="assembly. Finally, the E protein plays a role in"/>
 <result pre="in this paper) of the SARSâ€�CoVâ€�2 surface proteins After the" exact="viral" post="entry, the second step is the expression of replicase"/>
 <result pre="S protein (S1) to angiotensinâ€�converting enzyme 2 (ACE2) facilitates the" exact="viral" post="attachment. Viral fusion is primed by TMPRSS2, and the"/>
 <result pre="(S1) to angiotensinâ€�converting enzyme 2 (ACE2) facilitates the viral attachment." exact="Viral" post="fusion is primed by TMPRSS2, and the active spike"/>
 <result pre="the integrin. RGD is not found in other coronaviruses. The" exact="viral" post="RNA is unveiled by the effect of endosomal cathepsins"/>
 <result pre="cathepsins at low pH. Following, the replicase gene of the" exact="viral" post="genome is translated into large polyproteins which are cleaved"/>
 <result pre="is occurred in the cytoplasm, followed by budding into golgi" exact="intermediate" post="compartment. Then, the enveloped virus is exocytosed. Plausible drugs"/>
 <result pre="the compounds chloroquine (CQ) and remdesivir (RDV) effectively inhibited the" exact="infection" post="by SARSâ€�CoVâ€�2 with a high selectivity index at low"/>
 <result pre="Remdesivir RNA polymerase An adenine analogue that participates into nascent" exact="viral" post="RNA chains and causes in preâ€�mature termination Wang etÂ"/>
 <result pre="polymerase (RdRp) Wang etÂ al.Â (2020) Ribavirin RNA polymerase Inhibits" exact="viral" post="RNA synthesis and mRNA capping Khalili, Zhu, Mak, Yan,"/>
 <result pre="(RdRp) Li and De ClercqÂ (2020) Galidesivir RNA polymerase Inhibits" exact="viral" post="RNA polymerase function by terminating nonâ€�obligate RNA chain Li"/>
 <result pre="(2020) Ikarugamycin ACE2 ACE2 inhibitors that block the site of" exact="viral" post="spike protein interaction Yang, Li, Bai, and HouÂ (2020)"/>
 <result pre="ACE2 Yang etÂ al.Â (2020) Eriodictyol ACE2 Binding potency to" exact="viral" post="S protein at its host receptor or to the"/>
 <result pre="interface Smith and SmithÂ (2020) Nitrofurantoin ACE2 Binding potency to" exact="viral" post="S protein at its host receptor or to the"/>
 <result pre="interface Smith and SmithÂ (2020) Cepharanthine ACE2 Binding potency to" exact="viral" post="S protein at its host receptor or to the"/>
 <result pre="Teicoplanin Cathepsin L Antibiotic inhibiting the lowâ€�pH cleavage of the" exact="viral" post="spike protein by cathepsin L in the late endosomes"/>
 <result pre="Ciclesonide Endoribonuclease A corticosteroid that inhibits replication via inhibition of" exact="viral" post="nsp15 Matsuyama etÂ al.Â (2020) Camrelizumab Programmed cell death"/>
 <result pre="al.Â (2020) Umifenovir (Arbidol) ND Membrane fusion inhibitor targeting the" exact="viral" post="entry Li and De ClercqÂ (2020) Chloroquine/ hydroxychloroquine ND"/>
 <result pre="Ltd, This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
 <result pre="completed the clinical trial phase III for the purpose of" exact="viral infection" post="control caused by the Ebola virus. The remdesivir is"/>
 <result pre="the clinical trial phase III for the purpose of viral" exact="infection" post="control caused by the Ebola virus. The remdesivir is"/>
 <result pre="II NCT04276688 Lopinavir/ritonavir; Ribavirin; Interferon Betaâ€�1B Inhibition of protease and" exact="viral" post="mRNA synthesis II NCT04280588 Fingolimod Modulation of Sphingosine 1â€�phosphate"/>
 <result pre="Modulation of Sphingosine 1â€�phosphate receptor II NCT04273529 Thalidomide Inhibition of" exact="Inflammatory" post="cells and cytokines II NCT04288102 Biological: Mesenchymal stem cells"/>
 <result pre="Thalidomide Inhibition of Inflammatory cells and cytokines II NCT04288102 Biological:" exact="Mesenchymal" post="stem cells Possessing a comprehensive immunomodulatory function II NCT04317092"/>
 <result pre="Prostaglandin G/H synthase inhibition III NCT04304313 Sildenafil citrate cGMPâ€�specific phosphodiesterase" exact="type 5" post="(PDE5) inhibition III NCT04320615 Tocilizumab (TCZ) ILâ€�6â€�mediated signalling inhibition"/>
 <result pre="Ltd, This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
 <result pre="Identifier Interventions Mechanism of action Status (Phase) NCT04400838 ChAdOx1 Nonâ€�replicating" exact="viral" post="vector III NCT04379336 Bacille Calmetteâ€&quot;GuÃ©rin (BCG) Enhancing nonâ€�specific immune"/>
 <result pre="SARSâ€�CoVâ€�2 Inactivated II NCT04276896 LVâ€�SMENPâ€�DC Lentiviral vector system (NHP/TYF) expressing" exact="viral" post="proteins and immune modulatory genes to modify dendritic cells"/>
 <result pre="cells II NCT04383574 InactivatedÂ SARSâ€�CoVâ€�2 Inactivated II NCT04436471 Adenoâ€�based Nonâ€�replicating" exact="viral" post="vector II ChiCTR2000031781 Adenovirus Type 5 Vector Nonâ€�replicating viral"/>
 <result pre="Inactivated II NCT04436471 Adenoâ€�based Nonâ€�replicating viral vector II ChiCTR2000031781 Adenovirus" exact="Type 5" post="Vector Nonâ€�replicating viral vector II ChiCTR2000031809 InactivatedÂ SARSâ€�CoVâ€�2 Inactivated"/>
 <result pre="Nonâ€�replicating viral vector II ChiCTR2000031781 Adenovirus Type 5 Vector Nonâ€�replicating" exact="viral" post="vector II ChiCTR2000031809 InactivatedÂ SARSâ€�CoVâ€�2 Inactivated I/II ChiCTR2000032459 InactivatedÂ"/>
 <result pre="Inactivated I/II ChiCTR2000032459 InactivatedÂ SARSâ€�CoVâ€�2 Inactivated I/II NCT04368988 Recombinant Spike" exact="Protein" post="SARSâ€�CoVâ€�2Â Recombinant Spike Protein NanoparticleÂ vaccineÂ (SARSâ€�CoVâ€�2Â rS) with"/>
 <result pre="SARSâ€�CoVâ€�2 Inactivated I/II NCT04368988 Recombinant Spike Protein SARSâ€�CoVâ€�2Â Recombinant Spike" exact="Protein" post="NanoparticleÂ vaccineÂ (SARSâ€�CoVâ€�2Â rS) with or without MATRIXâ€�Mâ&quot;¢ Adjuvant"/>
 <result pre="for a fullâ€�length, spike (S) protein II NCT04313127 Ad5â€�nCoV Adenovirus" exact="type 5" post="vector that expresses S protein I NCT04336410 NOâ€�4800 DNA"/>
 <result pre="lentiviral vector expressing synthetic minigene based on domains of selected" exact="viral" post="proteins I (C) John Wiley &amp;amp; Sons, Ltd, This"/>
 <result pre="Ltd, This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
 <result pre="of surface alteration of RNA viruses, blocking the cell surface" exact="viral" post="receptor, thereby inhibiting the virus entry, can be a"/>
 <result pre="in designing the approach of drug discovery. Binding of the" exact="viral" post="spike (S) glycoproteins to cellular receptor ACE2 and priming"/>
 <result pre="entry. SARSâ€�CoVâ€�2 RNA is then released into the cytoplasm, and" exact="viral" post="replication is efficiently processed (TableÂ 4). TABLE 4 Principle"/>
 <result pre="Principle molecular targets of SARSâ€�CoVâ€�2 for drug discovery or design" exact="Viral" post="cycle Molecular targets Potential antiâ€�viral drugs Host attachment and"/>
 <result pre="ND Spike protein* EK1C4 Uncoating Ion channel proteins Amantadine Replicase" exact="Protein" post="Expression Papainâ€�like proteinase (PLpro) Mycophenolic acid, Grazoprevir, Formoterol, Telaprevir,"/>
 <result pre="(3CLpro)* Ritonavir, Nelfinavir, Lopinavir, Ebselen, Cinanserin, Ketoamide, Atazanavir, Replication ofÂ" exact="viral" post="genome RNAâ€�dependent RNA polymerase (RdRp)* Remdesivir, Baloxavir marboxil, Triazavirin,"/>
 <result pre="peptidyl/prolyl isomerases (PPIases) ND Nucleoside analogues Remdesivir, Favipiravir, ribavirin, 5â€�fluorouracil" exact="Viral" post="protein assembly Envelope protein (protein E) ND Cell release"/>
 <result pre="Ltd, This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
 <result pre="the public health emergency. 3.1.2 Angiotensinâ€�converting enzyme 2 (ACE2) A" exact="type I" post="membrane zinc metalloprotease named angiotensinâ€�converting enzyme 2 (ACE2) is"/>
 <result pre="(ACE2) is mainly expressed in arterial cells and lung alveolar" exact="epithelial" post="cells. ACE2 hydrolyses the angiotensin I to produce angiotensin"/>
 <result pre="the natalizumab antibody (Î±4Î²1/Î²7 integrin inhibitor) and the treatment of" exact="acute" post="coronary syndrome with the small molecule tirofiban (Î±IIbÎ²3 blocker)"/>
 <result pre="antibody (Î±4Î²1/Î²7 integrin inhibitor) and the treatment of acute coronary" exact="syndrome" post="with the small molecule tirofiban (Î±IIbÎ²3 blocker) are examples"/>
 <result pre="It was shown that the approved blockers can impair the" exact="infection" post="of major HCV variants in in vitro and in"/>
 <result pre="such as genistein can also block the replication of arenavirus," exact="herpes" post="simplex virus type 1 (HSVâ€�1) and HIVâ€�1 (Vela, Bowick,"/>
 <result pre="can also block the replication of arenavirus, herpes simplex virus" exact="type 1" post="(HSVâ€�1) and HIVâ€�1 (Vela, Bowick, Herzog, &amp;amp; Aronson,Â 2008)."/>
 <result pre="RTK inhibitor named (A9) as a competent blocker of transmissible" exact="gastroenteritis" post="virus (TGEV) infection belong to Alphacoronavirus genera as a"/>
 <result pre="(A9) as a competent blocker of transmissible gastroenteritis virus (TGEV)" exact="infection" post="belong to Alphacoronavirus genera as a successor model for"/>
 <result pre="(Dong etÂ al.,Â 2020). The inhibitors of RTK suppress the" exact="viral" post="replication through different mechanisms like interferon signalling, Raf/MEK/Erk pathway"/>
 <result pre="as a probable hostâ€�centred approach to treat the SARSâ€�CoVâ€�2. 3.1.5" exact="Viral" post="spike protein The trimeric S glycoprotein responsible for the"/>
 <result pre="introduced a lipopeptide named EK1C4 that effectively block the SARSâ€�CoVâ€�2" exact="infection" post="in in vitro experiments with IC50 of 36.5Â nM"/>
 <result pre="of genome uncoating The cessation of the capsid disintegration by" exact="viral" post="or host enzymes/proteins is a drug target explored against"/>
 <result pre="is a drug target explored against the influenza virus, rhinoviruses," exact="hepatitis" post="A, poliovirus and enteroviruses (Yamauchi &amp;amp; Greber,Â 2016). In"/>
 <result pre="blocking the viroporin E (a proton channel) and inhibiting the" exact="viral" post="uncoating (Aranda Abreu, HernÃ¡ndez Aguilar, Herrera Covarrubias, &amp;amp; Rojas"/>
 <result pre="antibodies that block the genome uncoating besides the blockage of" exact="viral" post="receptor (Chen etÂ al.,Â 2020). Furthermore, it is still"/>
 <result pre="expression Following the uncoating step, the replicase gene of the" exact="viral" post="genome encodes two processed polyproteins (pp) named pp1a and"/>
 <result pre="(pp) named pp1a and pp1ab (Chan etÂ al.,Â 2020). Then," exact="viral" post="proteinases perform postâ€�translational modification on the polyproteins yielding proteins"/>
 <result pre="on the polyproteins yielding proteins that mediate the formation of" exact="viral" post="replication complexes. The protease activities of all coronaviruses include"/>
 <result pre="Due to their unrivalled and essential function in processing the" exact="viral" post="polyprotein, these enzymes are appropriate targets for SARSâ€�CoVâ€�2 drug"/>
 <result pre="nsp3 releases proteins involved in both replication of coronavirus and" exact="infection" post="processes. In addition to the LXGG motif found inâ€�between"/>
 <result pre="or nsp5 directly mediates the polyprotein processing and maturation of" exact="viral" post="nonâ€�structural proteins (nsps), which is the indispensable part of"/>
 <result pre="nonâ€�structural proteins (nsps), which is the indispensable part of the" exact="viral" post="life cycle. Initiation of viral RNA synthesis and switching"/>
 <result pre="the indispensable part of the viral life cycle. Initiation of" exact="viral" post="RNA synthesis and switching translation to RNA replication are"/>
 <result pre="can be an attractive target for the intervention in the" exact="infection" post="progress. RNAâ€�dependent RNA polymerase (RdRp) (nsp12) or RNA replicase"/>
 <result pre="favipiravir (EC50Â =Â 61.88Â Î¼M) were needed to decrease the" exact="viral infection," post="while remdesivir (EC50Â =Â 0.77Â Î¼M) prevented the virus"/>
 <result pre="analogue via competing for ATP. Its incorporation by RdRp inhibits" exact="viral" post="replication through preâ€�mature termination of RNA synthesis. Importantly, remdesivir"/>
 <result pre="through preâ€�mature termination of RNA synthesis. Importantly, remdesivir inhibits the" exact="viral" post="replication in RNA viruses including positive and negative senses"/>
 <result pre="domain at the Câ€�terminus (Hel). This enzyme unfolds the firm" exact="secondary" post="structures of the genome in positiveâ€�sense RNA viruses to"/>
 <result pre="2012). Despite the essential function of helicase in virus multiplication," exact="limited" post="potential suppressors of nsp13 have been reported so far"/>
 <result pre="etÂ al.,Â 2005). 3.4.3 The peptidyl/prolyl isomerases (PPIases) The 18â€�kDa" exact="cytosolic" post="cyclophilin A is a necessary cellular molecule needed for"/>
 <result pre="group resulting in chain termination) are extensively applied for the" exact="hepatitis C" post="virus (HCV), hepatitis B virus (HBV), HIVâ€�1 and HSV"/>
 <result pre="termination) are extensively applied for the hepatitis C virus (HCV)," exact="hepatitis" post="B virus (HBV), HIVâ€�1 and HSV therapy. Compared to"/>
 <result pre="being as nucleoside analogue and the second is acting on" exact="viral" post="RdRp. Accordingly, Peters et al evaluated the efficiency of"/>
 <result pre="analogues can mitigate the resistance mediated by mutations in the" exact="viral" post="RdRp, perhaps by additive or synergistic interactions effect (Pruijssers"/>
 <result pre="analogue inhibitors hold promise for the treatment of SARSâ€�CoVâ€�2. 3.5" exact="Viral" post="protein assembly Capsid proteins have a pivotal function in"/>
 <result pre="that they are assembled in the endoplasmic reticulum and golgi" exact="intermediate" post="compartment (ERGIC) as the intracellular membranes and transported out"/>
 <result pre="&amp;amp; Fielding,Â 2019). The major part of E protein is" exact="localized" post="in intracellular trafficking and participates in coronavirus assembly, although"/>
 <result pre="in large quantities. The envelope protein (E) of coronaviruses (HCoVâ€�229E," exact="Mouse" post="hepatitis virus (MHV), IBV) mediates the assembly of virus"/>
 <result pre="large quantities. The envelope protein (E) of coronaviruses (HCoVâ€�229E, Mouse" exact="hepatitis" post="virus (MHV), IBV) mediates the assembly of virus and"/>
 <result pre="The involvement of E protein in pivotal stages of the" exact="viral" post="life cycle makes SARSâ€�CoVâ€�2 lacking E protein, a promising"/>
 <result pre="assembly with acylguanidine and cinnamoylguanidine reduced the SARSâ€�CoV and MHV" exact="viral" post="titre by 76 and 88% at a concentration of"/>
 <result pre="virus envelope. This protein also confirms the nucleocapsid stability, promotes" exact="viral" post="assembly and encapsulates the viral genome. Qin et al."/>
 <result pre="confirms the nucleocapsid stability, promotes viral assembly and encapsulates the" exact="viral" post="genome. Qin et al. designed siRNAs that degrade M"/>
 <result pre="for researches towards developing the new therapeutic agents for CoV" exact="infection" post="(Qin, Zhao, Cao, &amp;amp; Qi,Â 2007). The inhibition of"/>
 <result pre="infection (Qin, Zhao, Cao, &amp;amp; Qi,Â 2007). The inhibition of" exact="viral" post="assemble is investigated for different types of viruses including"/>
 <result pre="is investigated for different types of viruses including moloney murine" exact="leukaemia" post="virus (Moâ€�MLV) (McNally, Wahlin, &amp;amp; Cantoâ€�Soler,Â 2010), classical swine"/>
 <result pre="etÂ al.,Â 1995), HIVâ€�1 (Li etÂ al.,Â 2009), dengue virus" exact="type 2" post="(DENV2) (Qin etÂ al.,Â 2005), HBV (Seo etÂ al.,Â"/>
 <result pre="viruses from host cells as the last phase of the" exact="viral" post="cycle is an attractive strategy to minimize the dissemination"/>
 <result pre="of the virus mainly in pandemics to limit the released" exact="viral" post="load in the society. Drugs like zanamivir, oseltamivir, laninamivir"/>
 <result pre="oseltamivir, laninamivir octanoate and peramivir inhibit this step by targeting" exact="viral" post="neuraminidase to block the release of the Influenza virus"/>
 <result pre="is constitutively expressed in plasma cells, mature B cells and" exact="type I" post="interferonâ€�producing cells that can hinder the liberation of biosynthesized"/>
 <result pre="two novel coronaviruses have been emerged mainly causing the severe" exact="acute" post="respiratory syndrome coronavirus (SARSâ€�CoV) and Middle East respiratory syndrome"/>
 <result pre="novel coronaviruses have been emerged mainly causing the severe acute" exact="respiratory" post="syndrome coronavirus (SARSâ€�CoV) and Middle East respiratory syndrome coronavirus"/>
 <result pre="coronaviruses have been emerged mainly causing the severe acute respiratory" exact="syndrome" post="coronavirus (SARSâ€�CoV) and Middle East respiratory syndrome coronavirus (MERSâ€�CoV)"/>
 <result pre="the severe acute respiratory syndrome coronavirus (SARSâ€�CoV) and Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV) responsible for the epidemics in 2002"/>
 <result pre="severe acute respiratory syndrome coronavirus (SARSâ€�CoV) and Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV) responsible for the epidemics in 2002 and"/>
 <result pre="knowledge is still available on the biology of SARSâ€�CoVâ€�2 specially," exact="viral" post="protein synthesis and assembly and most of what we"/>
 <result pre="addition to the above approach, the detailed study of the" exact="viral" post="life cycle can lead to assigning some even more"/>
 <result pre="inhibit proteases affecting the replicase protein expression step in the" exact="viral" post="life cycle. While fullâ€�length S proteins of SARSâ€�CoVâ€�2 and"/>
 <result pre="tests until now, remdesivir seems a promising dualâ€�acting drug (inhibiting" exact="viral" post="RNA polymerases and 3Câ€�like main protease). Studies conducted so"/>
 <result pre="the immediate global need for drugs to control the SARSâ€�CoVâ€�2" exact="infection" post="drug search is currently pursued by the repurposing approach."/>
 <result pre="is currently pursued by the repurposing approach. Accordingly, the critical" exact="viral" post="life cycle steps like entry, genome and protein synthesis"/>
 <result pre="and protein synthesis reflect the multiple drug target groups not" exact="limited" post="to 3cl pro and RdRp that can be addressed"/>
 <result pre="value for drug repurposing or discovery programmes to hinder the" exact="viral" post="entry and fusion process. Considering the fact that the"/>
 <result pre="viral entry and fusion process. Considering the fact that the" exact="primary" post="goal of all viruses is to deliver and replicate"/>
 <result pre="L., Enjuanes, L., Weiss, S., &amp;amp; Sarafianos, S. G. (2012)." exact="Severe" post="acute respiratory syndrome coronavirus replication inhibitor that interferes with"/>
 <result pre="Enjuanes, L., Weiss, S., &amp;amp; Sarafianos, S. G. (2012). Severe" exact="acute" post="respiratory syndrome coronavirus replication inhibitor that interferes with the"/>
 <result pre="L., Weiss, S., &amp;amp; Sarafianos, S. G. (2012). Severe acute" exact="respiratory" post="syndrome coronavirus replication inhibitor that interferes with the nucleic"/>
 <result pre="Weiss, S., &amp;amp; Sarafianos, S. G. (2012). Severe acute respiratory" exact="syndrome" post="coronavirus replication inhibitor that interferes with the nucleic acid"/>
 <result pre="inhibitor that interferes with the nucleic acid unwinding of the" exact="viral" post="helicase. Antimicrobial Agents and Chemotherapy, 56, 4718â€&quot;4728. 10.1128/AAC.00957-1222733076 Adedeji,"/>
 <result pre="coronavirus spike protein is a class I virus fusion protein:" exact="Structural" post="and functional characterization of the fusion core complex. Journal"/>
 <result pre="the 2019 novel humanâ€�pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting Wuhan. Emerging Microbes &amp;amp; Infections, 9, 221â€&quot;236."/>
 <result pre="2019 novel humanâ€�pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting Wuhan. Emerging Microbes &amp;amp; Infections, 9, 221â€&quot;236."/>
 <result pre="Cyclosporine A and its nonâ€�immunosuppressive derivative NIM811 induce apoptosis of" exact="malignant melanoma" post="cells in in vitro and in vivo studies. International"/>
 <result pre="A and its nonâ€�immunosuppressive derivative NIM811 induce apoptosis of malignant" exact="melanoma" post="cells in in vitro and in vivo studies. International"/>
 <result pre="M., Tavakoliâ€�Ardakani, M., &amp;amp; Saffaei, A. (2020). Thalidomide against coronavirus" exact="disease" post="2019 (COVIDâ€�19): A medicine with a thousand faces. Iranian"/>
 <result pre="inhibits MERSâ€�and SARSâ€�coronavirus replication in cell culture, but not SARSâ€�coronavirus" exact="infection" post="in a mouse model. Virus Research, 228, 7â€&quot;13. 10.1016/j.virusres.2016.11.01127840112"/>
 <result pre="A inhibits the replication of diverse coronaviruses. The Journal of" exact="General" post="Virology, 92, 254210.1099/vir.0.034983-021752960 Dong, W., Xie, W., Liu, Y.,"/>
 <result pre="compound remdesivir potently inhibits RNAâ€�dependent RNA polymerase from Middle East" exact="respiratory" post="syndrome coronavirus. Journal of Biological Chemistry, 295, 4773â€&quot;4779. 10.1074/jbc.AC120.01305632094225"/>
 <result pre="remdesivir potently inhibits RNAâ€�dependent RNA polymerase from Middle East respiratory" exact="syndrome" post="coronavirus. Journal of Biological Chemistry, 295, 4773â€&quot;4779. 10.1074/jbc.AC120.01305632094225 Harrison,"/>
 <result pre="novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of" exact="hepatitis C" post="virus RNA replication in vitro. Antimicrobial Agents and Chemotherapy,"/>
 <result pre="Receptor tyrosine kinases as potential targets in the treatment of" exact="hepatitis C." post="Journal of Hepatology, 56, 282â€&quot;284. 10.1016/j.jhep.2011.06.02021784050 Jin, Z., Du,"/>
 <result pre="S. C. (2013). Assessing activity and inhibition of Middle East" exact="respiratory" post="syndrome coronavirus papainâ€�like and 3Câ€�like proteases using luciferaseâ€�based biosensors."/>
 <result pre="C. (2013). Assessing activity and inhibition of Middle East respiratory" exact="syndrome" post="coronavirus papainâ€�like and 3Câ€�like proteases using luciferaseâ€�based biosensors. Journal"/>
 <result pre="Hamel, A., Sibille, N., Yin, Y., â€¦ Lippens, G., (2010)." exact="Structural" post="basis for the nonâ€�immunosuppressive character of the cyclosporin A"/>
 <result pre="cyclophilin A to inhibit the assembly and uncoating of the" exact="viral" post="capsid. Bioorganic &amp;amp; Medicinal Chemistry, 17, 3177â€&quot;3188. 10.1016/j.bmc.2009.02.05119328002 Li,"/>
 <result pre="Lau, S. K.P, &amp;amp; Woo, P. C.Y (2019). Human Coronaviruses:" exact="General" post="Features. Reference Module in Biomedical Sciences, 2019. 10.1016/B978-0-12-801238-3.95704-0 Liu,"/>
 <result pre="Chupakhin, O. N. (2011). Therapeutic efficacy of Triazavirin, a novel" exact="Russian" post="chemotherapeutic, against influenza virus A (H5N1). Antibiotiki I Khimioterapiia,"/>
 <result pre="K., Kalpana, G. V., &amp;amp; Goff, S. P. (1993). Human" exact="immunodeficiency" post="virus type 1 Gag protein binds to cyclophilins A"/>
 <result pre="G. V., &amp;amp; Goff, S. P. (1993). Human immunodeficiency virus" exact="type 1" post="Gag protein binds to cyclophilins A and B. Cell,"/>
 <result pre="The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting" exact="viral" post="NSP15. BioRxiv, Preprint. 10.1101/2020.03.11.987016 McNally, M. M., Wahlin, K."/>
 <result pre="J., &amp;amp; Cantoâ€�Soler, M. V. (2010). Endogenous expression of ASLV" exact="viral" post="proteins in specific pathogen free chicken embryos: Relevance for"/>
 <result pre="chicken embryos: Relevance for the developmental biology research field. BMC" exact="Developmental" post="Biology, 10, 10610.1186/1471-213X-10-10620955591 Monini, P., Cafaro, A., Srivastava, I."/>
 <result pre="â€¦ Stebbing, J. (2020). Baricitinib as potential treatment for 2019â€�nCoV" exact="acute" post="respiratory disease. Lancet, 395, e3010.1016/S0140-6736(20)30304-432032529 Rosa, S. G. V.,"/>
 <result pre="Stebbing, J. (2020). Baricitinib as potential treatment for 2019â€�nCoV acute" exact="respiratory" post="disease. Lancet, 395, e3010.1016/S0140-6736(20)30304-432032529 Rosa, S. G. V., &amp;amp;"/>
 <result pre="PÃºblica, 4410.26633/RPSP.2020.40 Saraswat, S., Chaudhary, M., &amp;amp; Sehgal, D. (2020)." exact="Hepatitis" post="E virus cysteine protease has papain like properties validated"/>
 <result pre="silico modeling and cellâ€�free inhibition assays. Frontiers in Cellular and" exact="Infection" post="Microbiology, 9, 47810.3389/fcimb.2019.0047832039053 Schoeman, D., &amp;amp; Fielding, B. C."/>
 <result pre="J., &amp;amp; Jung, G. (2019). Cetylpyridinium chloride interaction with the" exact="hepatitis" post="B virus core protein inhibits capsid assembly. Virus Research,"/>
 <result pre="An orally bioavailable broadâ€�spectrum antiviral inhibits SARSâ€�CoVâ€�2 in human airway" exact="epithelial" post="cell cultures and multiple coronaviruses in mice. Science Translational"/>
 <result pre="(2020). Repurposing therapeutics for covidâ€�19: Supercomputerâ€�based docking to the sarsâ€�covâ€�2" exact="viral" post="spike protein and viral spike proteinâ€�human ace2 interface. ChemRxiv,"/>
 <result pre="covidâ€�19: Supercomputerâ€�based docking to the sarsâ€�covâ€�2 viral spike protein and" exact="viral" post="spike proteinâ€�human ace2 interface. ChemRxiv, Preprint. 10.26434/chemrxiv.11871402.v4 Stebbing, J.,"/>
 <result pre="P. (2020). COVIDâ€�19: Combining antiviral and antiâ€�inflammatory treatments. The Lancet" exact="Infectious" post="Diseases, 20, 400â€&quot;402. 10.1016/S1473-3099(20)30132-832113509 Stower, H. (2020). Lopinavirâ€�ritonavir in"/>
 <result pre="Bernbaum, J. G., Venkataraman, T., â€¦ Frieman, M. B. (2015)." exact="Severe" post="acute respiratory syndrome coronavirus ORF7a inhibits bone marrow stromal"/>
 <result pre="J. G., Venkataraman, T., â€¦ Frieman, M. B. (2015). Severe" exact="acute" post="respiratory syndrome coronavirus ORF7a inhibits bone marrow stromal antigen"/>
 <result pre="G., Venkataraman, T., â€¦ Frieman, M. B. (2015). Severe acute" exact="respiratory" post="syndrome coronavirus ORF7a inhibits bone marrow stromal antigen 2"/>
 <result pre="Venkataraman, T., â€¦ Frieman, M. B. (2015). Severe acute respiratory" exact="syndrome" post="coronavirus ORF7a inhibits bone marrow stromal antigen 2 virion"/>
 <result pre="M., Berline, J. W., &amp;amp; Palefsky, J. M. (2003). Epsteinâ€�Barr" exact="virus infection" post="of polarized tongue and nasopharyngeal epithelial cells. Nature Medicine,"/>
 <result pre="Berline, J. W., &amp;amp; Palefsky, J. M. (2003). Epsteinâ€�Barr virus" exact="infection" post="of polarized tongue and nasopharyngeal epithelial cells. Nature Medicine,"/>
 <result pre="M. (2003). Epsteinâ€�Barr virus infection of polarized tongue and nasopharyngeal" exact="epithelial" post="cells. Nature Medicine, 9, 307â€&quot;314. 10.1038/nm830 Van Damme, N.,"/>
 <result pre="release and is downregulated from the cell surface by the" exact="viral" post="Vpu protein. Cell Host &amp;amp; Microbe, 3, 245â€&quot;252. 10.1016/j.chom.2008.03.00118342597"/>
 <result pre="Shimotohno, K. (2005). Cyclophilin B is a functional regulator of" exact="hepatitis C" post="virus RNA polymerase. Molecular Cell, 19, 111â€&quot;122. 10.1016/j.molcel.2005.05.01415989969 Wilson,"/>
 <result pre="channels. Virology, 330, 322â€&quot;331. 10.1016/j.virol.2004.09.03315527857 collab: World Health Organization (2003)." exact="Severe" post="Acute Respiratory Syndrome (SARS) in Taiwan, China. Retrieved from"/>
 <result pre="Virology, 330, 322â€&quot;331. 10.1016/j.virol.2004.09.03315527857 collab: World Health Organization (2003). Severe" exact="Acute" post="Respiratory Syndrome (SARS) in Taiwan, China. Retrieved from https://www.who.int/csr/don/2003_12_17/en/"/>
 <result pre="330, 322â€&quot;331. 10.1016/j.virol.2004.09.03315527857 collab: World Health Organization (2003). Severe Acute" exact="Respiratory" post="Syndrome (SARS) in Taiwan, China. Retrieved from https://www.who.int/csr/don/2003_12_17/en/ collab:"/>
 <result pre="322â€&quot;331. 10.1016/j.virol.2004.09.03315527857 collab: World Health Organization (2003). Severe Acute Respiratory" exact="Syndrome" post="(SARS) in Taiwan, China. Retrieved from https://www.who.int/csr/don/2003_12_17/en/ collab: World"/>
 <result pre="â€¦ Kappes, J. C. (1995). Targeting foreign proteins to human" exact="immunodeficiency" post="virus particles via fusion with Vpr and Vpx. Journal"/>
 <result pre="Q., Feng, S., â€¦ Liu, S. (2020). Inhibition of SARSâ€�CoVâ€�2" exact="infection" post="(previously 2019â€�nCoVSARSâ€�COVâ€�2) by a highly potent panâ€�coronavirus fusion inhibitor"/>
 <result pre="(2001). Î±6 integrin is the main receptor of human papillomavirus" exact="type 16" post="VLP. Biochemical and Biophysical Research Communications, 283, 668â€&quot;673. 10.1006/bbrc.2001.483811341777"/>
 <result pre="Y. (2020). Potential interventions for novel coronavirus in China: A" exact="systemic" post="review. Journal of Medical Virology, 10.1002/jmv.25707 Zhou, B., Liu,"/>
 <result pre="B., Zhang, L., Zhang, W., â€¦ Shi, Z.â€�L. (2020). A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
</results>
